What's in the queue.

A standing place for QAI Labs announcements. Where a release is upcoming, the slot is held so partners and journalists can see what is in the queue.

Upcoming
2026
QAI Labs Ltd. launches NOVA-3 platform for multi-specific antibody design Placeholder slot · platform launch announcement covering the five-layer NOVA-3 architecture, the three internal programs, and Evidence Bundle provenance. Headline subject to change before issue.
Release
Placeholder
Upcoming
2026
QAI Labs signs first pharma BD partnership for NOVA-3 Placeholder slot · first signed pharma BD partnership announcement. Counterparty and program scope to be named at issue.
Release
Placeholder
Upcoming
2027
QAI Labs supports first IND filing on a NOVA-3 designed candidate Placeholder slot · first IND filing supported by a NOVA-3 designed lead candidate. Program identity and partner lab to be named at issue, subject to regulatory disclosure timing.
Release
Placeholder
Media contact
For interview requests, fact-checks, and embargoed briefings: press@qailabs.co
Partner with us →